Man Group PLC Eli Lilly & CO Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Man Group PLC holds 273,525 shares of LLY stock, worth $210 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

273,525

Previous 347,273 21.24%

Holding current value

$210 Million

Previous $314 Million 22.93%

% of portfolio

0.67%

Previous 0.84%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $56.9 Million - $70.8 Million	-73,748 Reduced 21.24%	273,525 $242 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $24 Million - $30.1 Million	33,091 Added 10.53%	347,273 $314 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $76.7 Million - $103 Million	129,561 Added 70.18%	314,182 $244 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $54.9 Million - $64.7 Million	104,547 Added 130.56%	184,621 $108 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $1.98 Million - $2.73 Million	-4,548 Reduced 5.37%	80,074 $43 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $13.5 Million - $18.1 Million	-38,614 Reduced 31.33%	84,622 $39.7 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $4.66 Million - $5.47 Million	15,005 Added 13.86%	123,236 $42.3 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $14.5 Million - $16.9 Million	45,239 Added 71.82%	108,231 $39.6 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $11.3 Million - $12.9 Million	-38,193 Reduced 37.75%	62,992 $20.4 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $4.26 Million - $5.01 Million	15,298 Added 17.81%	101,185 $32.8 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $128,610 - $159,829	548 Added 0.64%	85,887 $24.6 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $15.2 Million - $18.8 Million	-67,445 Reduced 44.14%	85,339 $23.6 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $2.42 Million - $2.98 Million	10,935 Added 7.71%	152,784 $35.3 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $21.9 Million - $28.3 Million	-121,293 Reduced 46.09%	141,849 $32.6 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $11.7 Million - $15.2 Million	71,313 Added 37.18%	263,142 $49.2 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $4.28 Million - $5.66 Million	-32,771 Reduced 14.59%	191,829 $32.4 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $9.24 Million - $10.7 Million	63,217 Added 39.17%	224,600 $33.2 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $1.28 Million - $1.54 Million	-9,363 Reduced 5.48%	161,383 $26.5 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $2.15 Million - $2.66 Million	18,050 Added 11.82%	170,746 $23.7 Million
Q4 2019 Feb 18, 2020	BUY	$106.92 - $132.43 $3.59 Million - $4.45 Million	33,581 Added 28.19%	152,696 $20.1 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $1.26 Million - $1.38 Million	-11,844 Reduced 9.04%	119,115 $13.3 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $15.3 Million - $17.8 Million	-137,859 Reduced 51.28%	130,959 $14.5 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $11.8 Million - $13.9 Million	-105,865 Reduced 28.25%	268,818 $34.9 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $15.2 Million - $17 Million	-143,361 Reduced 27.67%	374,683 $43.4 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $17.8 Million - $22.3 Million	207,719 Added 66.94%	518,044 $55.6 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $4.67 Million - $5.36 Million	61,727 Added 24.83%	310,325 $26.5 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $18.4 Million - $21.8 Million	248,598 New	248,598 $19.2 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account